EQUITIES IRHub

[Penny Machine]

Good Morning & Welcome Back Icequity

[ICEQUITY]

[1/10/12 3:48:49 PM] iceQuity: 1/10/12 Most Active Stocks
[1/10/12 3:48:52 PM] iceQuity: Symbol Name Price Chg % Chg Volume
TGGI
Trans Global Group (pc)
0.0002 0.0000 0.00% 286,842,300
RIGH
Rightsmile (pc)
0.0003 0.0001 50.00% 269,309,476
GOIG
Goip Global (pl)
0.0001 -0.0001 -50.00% 110,411,586
SMHS
Smart Holdings (pc)
0.0002 -0.0001 -33.33% 103,344,292
CGFIA
Colorado Goldfields A (q
0.0002 0.0000 0.00% 74,759,317
IJJP
Ijj Corp (pc)
0.0005 -0.0001 -16.67% 66,399,656
KMAG
Kma Global Sltns Intl (p
0.0010 -0.0008 -44.44% 64,288,378
ONTC
Onteco Corporation (qb)
0.0003 0.0000 0.00% 61,992,081
BRZM
Sierra Desert Hldgs (pn)
0.0010 0.0003 42.86% 61,357,992
KGRI
Kiley Group (pc)
0.0002 0.0000 0.00% 47,612,499
[1/10/12 3:49:20 PM] iceQuity: OTCBB
[1/10/12 3:49:22 PM] iceQuity: Symbol Name Price Chg % Chg Volume
GNTA
Genta
0.0026 0.0001 4.00% 60,469,606
CBIS
Cannabis Science
0.0318 0.0123 63.08% 39,737,754
ACTC
Advanced Cell Tech
0.1600 0.0130 8.84% 37,179,878
NEOM
Neomedia Techs
0.0160 0.0052 48.15% 28,555,381
NXOI
Next 1 Interactive
0.0020 -0.0002 -9.09% 27,690,699
SAVW
Savwatt Usa, Inc.
0.0005 0.0001 25.00% 25,484,448
ADRN
Adarna Energy Corp
0.0003 0.0000 0.00% 21,434,666
PTEL
Pegasus Tel
0.0001 -0.0001 -50.00% 21,042,000
IMDS
Imaging Diagnstc Sys
0.0026 -0.0005 -16.13% 19,652,722
AQLV
Aqualiv Technologies
0.0155 0.0000 0.00% 18,709,065
[1/10/12 3:49:39 PM] iceQuity: AMEX
[1/10/12 3:49:42 PM] iceQuity: Symbol Name Price Chg % Chg Volume
REE
Rare Element Resources L
6.13 -0.65 -9.59% 7,946,094
LNG
Cheniere
8.70 -0.09 -1.02% 4,155,360
AVL
Avalon Rare Metals Ordin
2.90 -0.15 -4.92% 2,098,924
RTK
Rentech Common Stock
1.58 0.02 1.28% 1,938,844
DEJ
Dejour Energy Inc. Ltd O
0.49 -0.03 -5.77% 1,835,762
GSS
Golden Star
1.75 0.02 1.16% 1,831,218
TGB
Taseko Mines
3.00 0.20 7.14% 1,579,076
NGD
New Gold
11.02 0.29 2.70% 1,539,336
GSX
Gasco
0.26 0.01 4.00% 1,534,640
GBG
Great Basin Gold, Ltd. C
1.10 0.02 1.85% 1,499,210
[1/10/12 3:49:55 PM] iceQuity: NASDAQ
[1/10/12 3:49:58 PM] iceQuity: Symbol Name Price Chg % Chg Volume
REE
Rare Element Resources L
6.13 -0.65 -9.59% 7,946,094
LNG
Cheniere
8.70 -0.09 -1.02% 4,155,360
AVL
Avalon Rare Metals Ordin
2.90 -0.15 -4.92% 2,098,924
RTK
Rentech Common Stock
1.58 0.02 1.28% 1,938,844
DEJ
Dejour Energy Inc. Ltd O
0.49 -0.03 -5.77% 1,835,762
GSS
Golden Star
1.75 0.02 1.16% 1,831,218
TGB
Taseko Mines
3.00 0.20 7.14% 1,579,076
NGD
New Gold
11.02 0.29 2.70% 1,539,336
GSX
Gasco
0.26 0.01 4.00% 1,534,640
GBG
Great Basin Gold, Ltd. C
1.10 0.02 1.85% 1,499,210
[1/10/12 3:50:13 PM] iceQuity: Nasdaq
[1/10/12 3:50:16 PM] iceQuity: Symbol Name Price Chg % Chg Volume
BAC
Bank Of America
6.63 0.36 5.74% 353,671,638
F
Ford Motor
11.80 0.00 0.00% 121,713,373
HMA
Health Management
6.05 -0.91 -13.07% 68,338,610
EK
Eastman Kodak
0.60 0.20 49.96% 67,794,658
AA
Alcoa
9.44 0.02 0.16% 64,176,099
GE
Gen Electric
18.72 -0.14 -0.74% 59,330,723
C
Citigroup New Common Sto
30.00 0.92 3.16% 47,647,570
JPM
Jp Morgan Chase
36.05 0.75 2.12% 35,973,467
NOK
Nokia
5.39 0.16 3.06% 33,023,929
S
Sprint Nextel
2.23 0.03 1.36% 29,952,023
[1/10/12 3:54:18 PM] iceQuity: TSX
[1/10/12 3:54:24 PM] iceQuity: Symbol Name Last Change
NXY.TSX Nexen Inc 17.28 0.23 (1.349%)
COS.TSX Canadian Oil Sands Ltd 23.74 -0.15 (-0.628%)
AC.B.TSX Air Canada 1.08 0.01 (0.935%)
AQN.TSX Algonquin Power & Utilities Corp 6.35 -0.07 (-1.09%)
CLL.TSX Connacher Oil & Gas Ltd 0.87 0.01 (1.163%)
CLQ.TSX Canada Lithium Corp 0.48 0.025 (5.495%)
QUX.TSX Quadra FNX Mining Ltd 15.18 0.06 (0.397%)
MFC.U.TSX Manulife Financial Corp 11.43 0.01 (0.088%)
CRK.TSX Crocodile Gold Corp 0.55 0.03 (5.769%)
SU.TSX Suncor Energy Inc 31.55 0.09 (0.286%)
G.TSX Goldcorp Inc 45.2 -0.75 (-1.632%)
HNU.TSX Horizons BetaPro NYMEX Natural Gas Bull Plus ETF 7.37 0.47 (6.812%)
ML.TSX Mercator Minerals Ltd 1.7 -0.04 (-2.299%)
K.TSX Kinross Gold Corp 12.67 0.26 (2.095%)
YLO.TSX Yellow Media Inc 0.23 0.005 (2.222%)
RY.TSX Royal Bank of Canada 52.05 -0.29 (-0.554%)
TLM.TSX Talisman Energy Inc 12.68 -0.73 (-5.444%)
LSG.TSX Lake Shore Gold Corp 1.43 0.06 (4.38%)
CMK.TSX Cline Mining Corp 1.91 -0.16 (-7.729%)
XIU.TSX iShares S&P/TSX 60 Index Fund 17.41 -0.07 (-0.4%)
STP.TSX Southern Pacific Resource Corp 1.54 0.02 (1.316%)
AQN.DB.B.TSX 7 ALG 17 SCVDEBS 152.08 -1.61 (-1.048%)
PRQ.DB.B.TSX 5.25 PROG14 SCV PIK 104 0 (0%)
BBD.B.TSX Bombardier Inc 4.16 0 (0%)
ELR.TSX Eastern Platinum Ltd 0.57 0 (0%)
[1/10/12 3:54:48 PM] iceQuity: TSXV
[1/10/12 3:54:52 PM] iceQuity: Symbol Name Last Change
GNM.TSXV GeoNovus Minerals Corp 0.095 -0.005 (-5%)
VST.TSXV Vast Exploration Inc 0.07 0.01 (16.667%)
LS.TSXV Lakeside Steel Inc 0.265 -0.005 (-1.852%)
EZ.TSXV Encore Renaissance Resources Corp 0.04 0.005 (14.286%)
CAN.TSXV Canaco Resources Inc 1.49 -0.08 (-5.096%)
KNE.TSXV Kane Biotech Inc 0.105 0.015 (16.667%)
RIO.TSXV Rio Alto Mining Ltd 3.65 0.11 (3.107%)
MNP.WS.TSXV Manas Petroleum Corp 0.01 0 (0%)
RDA.TSXV Royal Coal Corp 0.065 0 (0%)
IB.TSXV IBC Advanced Alloys Corp 0.16 0 (0%)
AAN.TSXV Alexander Nubia International Inc 0.08 0.01 (14.286%)
MRP.TSXV Mira Resources Corp 0.205 0.02 (10.811%)
ETR.TSXV EACOM Timber Corp 0.085 0.02 (30.769%)
BOE.TSXV Americas Petrogas Inc 3.4 0.31 (10.032%)
COU.TSXV Cougar Minerals Corp 0.03 0.02 (200%)
SLC.TSXV Serebra Learning Corp 0.08 0.015 (23.077%)
RHR.TSXV Redhill Resources Corp 0.12 0.015 (14.286%)
MEX.TSXV Midlands Minerals Corp 0.06 0.015 (33.333%)
ZNR.TSXV Zone Resources Inc 0.125 0.01 (8.696%)
NVS.TSXV Novus Energy Inc 0.79 0.02 (2.597%)
WAI.TSXV West African Iron Ore Corp 0.17 0.045 (36%)
FNC.TSXV Fancamp Exploration Ltd 0.31 0 (0%)
SNM.TSXV ShaMaran Petroleum Corp 0.335 0.02 (6.349%)
BBB.TSXV Brixton Metals Corp 0.2 -0.05 (-20%)
CAJ.TSXV Canasia Industries Corp 0.05 0.02 (66.667%)
[1/10/12 3:56:38 PM] iceQuity: OTCBB Gainers
[1/10/12 3:56:42 PM] iceQuity: Symbol Name Last Change
CFRI Conforce International Inc 0.299 0.099 (49.5%)
CPFH Capital Financial Holdings Inc 0.07 0.023 (48.936%)
ADRN Adarna Energy Corp 0.0003 0 (0%)
XNYH Xinyinhai Technology Ltd 0.03 0.01 (50%)
AOXY Advanced Oxygen Technologies Inc 0.008 0.003 (60%)
RVBHF R.V.B. Holdings Ltd 0.108 0.038 (54.286%)
PWBO Pacific West Bank West Linn Oregon 0.95 0.33 (53.226%)
FFFC FastFunds Financial Corp 0.06 0.02 (50%)
CHMD China Media Group Corp 0.0075 0.003 (65.217%)
VVIT Vista International Technologies Inc 0.03 0.015 (98.039%)
ITCC InsPro Technologies Corp 0.0336 0.014 (70%)
CICI Communication Intelligence Corp 0.08 0.034 (73.913%)
AAAA AAA Pub Adjusting Group Inc 0.014 0.006 (75%)
TAEC Todays Alternative Energy Corp 0.12 0.052 (77.037%)
VKML Viking Minerals Inc 0.009 0.004 (80%)
LCTZ La Cortez Energy Inc 0.2 0.09 (81.818%)
PROT Proteonomix Inc 0.95 0.43 (82.692%)
TXTM ProText Mobility Inc 0.015 0.007 (87.5%)
SNAX Healthient Inc 0.16 0.075 (88.235%)
BAZI Bazi International Inc 0.02 0.01 (95.238%)
TUCN TouchIT Technologies Inc 0.02 0.01 (95.238%)
PTEL Pegasus Tel Inc 0.0002 0 (0%)
NXMR NextMart Inc 0.0019 0.001 (142.857%)
VNDB Vendum Batteries Inc 0.035 0.019 (118.75%)
MKAU MK Automotive Inc 0.13 0.09 (225%)
[1/10/12 3:57:18 PM] iceQuity: Symbol    Name    Last    Change
CBTEQ    Commonwealth Biotechnologies Inc    0.0399    0.027 (207.692%)
TUIC    Transportation Components Inc    0.003    0.002 (200%)
MBST    Mobile Star    0.0006    0 (0%)
CCAJ    Coastal Capital Acquisition Corp    0.0014    0.001 (250%)
FCPN    First Capital International Inc    0.001    0.001 (333.333%)
GHRI    Goliath Resources Inc    0.05    0.035 (233.333%)
WHCI    W Holding Company Inc    0.09    0.065 (260%)
IMMCQ    Immunicon Corp    0.0088    0.007 (350%)
GBLE    Global 8 Environmental Technologies Inc    0.0235    0.018 (360%)
FPBN    First Pacific Bancorp    0.01    0.008 (380.952%)
SNMBQ    Sona Mobile Holdings Corp    0.0005    0 (0%)
STMC    Smart SMS Corp    0.003    0.002 (400%)
CGDI    China Growth Development Inc    0.006    0.005 (500%)
VYTR    Vyteris Inc    0.13    0.109 (519.048%)
TRUL    Trulite Inc    0.25    0.21 (525%)
SAMB    Sun American Bancorp    0.014    0.012 (600%)
IXOG    Index Oil & Gas Inc    0.004    0.004 (800%)
HBWO    Harbor Brewing Co Inc    0.74    0.64 (640%)
CNWT    Cistera Networks Inc    0.155    0.134 (638.095%)
CTQN    Cash Technologies Inc    0.005    0.004 (666.667%)
APLD    Applied Science Products Inc    0.01    0.009 (750%)
GTGR    Golden Tech Group Ltd    0.01    0.009 (900%)
SHCG    Sharewell Capital Group Inc    0.9    0.869 (2794.212%)
SIMA    Sonics & Materials Inc    4.9    4.68 (2127.273%)
RGFCQ    R & G Financial Corp    0.001    0.001 (1000%)

[ICEQUITY]

TICKER BUZZ CLOUDD 4:42:00 AM
Ticker Buzz Cloud (1 hour)
Time Interval: 24hr | 12hr | 6hr | 3hr | 1hr
AAGH AAPL ABIO ABOT ADSK ADXS AGQ ALJ ALJJ ALU ALZM AMGN AMR AMZN ANDI APNX ASX ASX ATIG BAC BCAP BDTE BEST BIEL BRY BSX CAGR CAK CALL CAMS CBAI CBBD CBWP CCEL CEO CHBT CHK CHPN CIM CLNT CLWR CMCSA CME CMGO CNLG CNSC CNWD CSCO CUYC CVSL DCTH DENN DOW DRFO DTG DUK DUNR DUSS EDIG ENTI EPTI ESTE EUR EVCA EVEP EXPU EXTO FCCN FEEL FLRE FNFG FOGC FTR FTWR FXPT GAIMF GBG GBTR GIII GIMU GMCR GMND GOLD GPS GRDO GRPN GSS GSX HANS HAR HBRM HKFI HMPR HRAL IBM IDCC IGXT INHX INTC JBII JEF JPM KEYP KNOS LBSR LNG LULU LWSP MASP MDFI MDGC MEG MFGLQ MFN MLXO MMTE MSFT MUTA MYFT NCEN NDX NEON NGD NOG NPHC NRTI NSRS NTUR NVIV NYA NYSE NYSE OCZ OIL ONTC OPEN OTCM OTCQX OXY PAL PALL PANL PBGC PDGO PDOS PFE PGMI PHAR PLX PPRW PSPW QQQ QQQ QQQ QQQ RAYS RBTI RIMM RKT RNN RPMGF RTIX RTK SAPX SBUX SDRC SHLD SHSH SIRI SNP SNTL SNWRF SRCP SRRY SRSR SSN STAU SUGO SYMX TGAL TGGI THES THRA THWI TPIV TRDY TSNP TVIPF ULTA UPL UXG VIX VTG WAG WAMUQ WEST WFC WRES XYTS YHOO YMI ZPCM ZSL
http://investorshub.advfn.com/boards/tcloud2.aspx?i=1

Ticker Buzz Cloud (3 hours)
AAGH AAPL ABIO ABOT ALJ ALJJ AMZN APNX ATIG BRY CAGR CAMS CBAI CBWP CEO CHPN CNWD CURX CUYC CVSL DOW DUNR DUSS EXTO FLRE FOGC FTCH FXPT GBTR GOLD GPS GSS HBRM HRAL JBII KATX LBSR LNG LWSP MDFI MFN MMTC MNDO MUTA MWWC MYFT NOG NSRS NYSE NYSE OTCM OTCQX SIRI SMNG SNWRF SSN STAU SUGO TDGI TGAL TGGI UXG VTG YMI
http://investorshub.advfn.com/boards/tcloud2.aspx?i=3


Ticker Buzz Cloud (6 hours)
AAVG ABOT ALJ ALJJ AMZN ARDM ATRN BFHJ BGBV BRVO CAGR CBAI CBWP CEO DUNR EFIR EGOC ENRT EXTO FTCH FXPT GBTR GOLD GRDO HBRM HESG HLNT IWEB JBII LBSR LIVE MCET MMTC MMTE MWWC MYFT NBRI NSRS NTRO NXOI NYSE NYSE OIL ONTC OTCQX PFE PGIE PHAR PVSP PYCT REAL RFMK SEEK SEEK SFIO SHKZ SHMX SIOR SMKY SNEY SRGE STAU SUGO TDGI TEVA TGAL TGGI TYP UXG WTI
http://investorshub.advfn.com/boards/tcloud2.aspx?i=6

Ticker Buzz Cloud (12 hours)
AAVG ATRN BEST BFHJ BKUNQ CAGR CEO ELRA ENTI EXTO FBN GBTR GEAR GOLD GRDO HBRM HESG HFBG HLNT ICPA JBII KBLB LYJN MDHI MMTC MMTE MNLU MWIP MWWC NSRS NTRO NYSE NYSE OIL OTCQX PEIX PHAR PTEL PVSP PYCT REAL RFMK SAPX SEEK SEEK SFIO SHO SIOR SMKY SNEY SSHS SUGO TDGI TGGI TYP
http://investorshub.advfn.com/boards/tcloud2.aspx?i=12

Ticker Buzz Cloud (24 hours)
AAVG ABOT AMR ATRN BEST BFHJ CAGR CBAI CCEL CEO CWRN ELRA EMLL ENTI EXTO FBN GBTR GEAR HBRM HESG HFBG ICPA JBII KBLB KGRI MDHI MMTC MWWC NSRS NTRO NWMT NYSE NYSE OIL OPMG OTCQX PEIX PVSP PYCT REAL RFMK SAPX SEEK SEEK SFIO SHKZ SIOR SMKY SNEY SUGO TAT TDGI TGGI
http://investorshub.advfn.com/boards/tcloud2.aspx?i=24

351 Views
http://ih.advfn.com/videos/stock-research/i-see-equity-in-gbtr-equities-com-r-m-1-4-r-s_Gn7e3FIGO58

[ICEQUITY]

Happy New Year! There is more to this Universe then Politics and Money...

Here are some post that I like.

You are walking on the earth as in a dream. Our world is a dream within a dream; you must realize that to find God is the only goal, the only purpose, for which you are here. For Him alone you exist. Him you must find. ~ Paramahansa Yogananda http://investorshub.advfn.com/boards/read_msg.aspx?message_id=70264662&txt2find=fellowship|shrine

It is we who are ‘the beast’…
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=70110376

Always Remember

But Money ranks up there with Air & Water:)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=70051212

Mic Stockwell - Capitalism is like a vehicle... It is the drunk behind the wheel that makes the vehicle dangerous. Capitalism has no feelings or remorse, people should... What other economic system would you suggest? Technocapitalism? I would agree where creativity and new knowledge become the most valuable resources. - IMO

We are water, light, sound & energy people... Many things effect who we are - IMO

Wouldn't you agree that those elements of who we are should be given the utmost important... When it comes to government trying to prescribe those things for us? What will come next prescribed channels we must view or listen too? How much light or what type of water we must consume?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=70413220

I forgot the most important type of people we are... Loving
Peace in 2012

ICEQUITY STOCK PICK OF 2012 - GBTR

http://ih.advfn.com/videos/stock-research/i-see-equity-in-gbtr-equities-com-r-m-1-4-r-s_Gn7e3FIGO58

[ICEQUITY]

Internet - Information/Portals Message Boards on Investors Hub

Ticker Board Name Total Posts Latest Post
FFN Friend Finder Network 43 12/22/2011 08:48:10 PM
BRYN Bryn Resources Inc 5,929 12/22/2011 11:37:07 AM
YHOO Yahoo! 456 12/22/2011 10:21:53 AM
EGOV NIC, Inc. 50 12/22/2011 09:19:18 AM
BIDU Baidu.com Inc 1,034 12/22/2011 12:07:58 AM
AOL AOL INC. 134 12/21/2011 09:37:39 AM
QPSA Quepasa Corp. 4,314 12/20/2011 02:08:09 PM
YNDX Yandex, N. V. 131 12/20/2011 12:14:12 PM
ANGI Angies List, Inc., 4 12/16/2011 01:17:59 PM
RENN Renren Inc. 377 12/15/2011 08:33:53 AM
EDGR EDGAR Online, Inc. 10 12/07/2011 11:16:25 PM
ZVUE Handheld Entertainment Inc. 422 12/07/2011 12:34:22 PM
BLNKF Blinkx PLC 356 11/29/2011 08:54:08 AM
JNPR Juniper 128 11/07/2011 08:18:25 AM
JRJC China Finance Online Co Ltd 39 10/29/2011 11:05:07 PM
TST Thestreet, Inc. 8 10/14/2011 11:40:03 AM
ACOM Ancestry.Com 7 09/29/2011 12:45:24 PM
BLEW Bluewave Group, Inc. 418 09/10/2011 04:49:38 PM
ITLI Intelligentias, Inc 181 08/29/2011 03:47:17 PM
CRMZ Creditriskmonitor.Com 1 08/08/2011 05:14:33 PM
BIZZ Bizzingo 13 08/04/2011 12:45:23 PM
CBR Ciber, Inc. 15 08/03/2011 11:55:01 PM
INSP InfoSpace, Inc. 142 07/13/2011 12:07:20 AM
FENG Phoenix New Media Ltd 6 07/06/2011 07:18:05 PM
VNET 21 Vianet Group 1 05/20/2011 02:19:26 PM
ISD iSIGN Media Solutions Inc. 10 04/29/2011 10:35:26 AM
KUTV KU6 Media CO., Ltd. 4 04/28/2011 10:12:46 AM
LEDR Market Leader, Inc. 0 04/20/2011 11:58:07 AM
ANSW Answers.com 2,048 02/11/2011 06:25:27 PM
TCX Tucows Inc 71 02/08/2011 10:53:33 AM
EPIC Epicor Software 0 01/27/2011 04:31:09 PM
IIIIW Information Systems Inc 8 10/17/2010 11:25:05 PM
HSWI HowStuffWorks 43 07/31/2010 04:01:00 AM
SPLN SportsLine.com 5 10/19/2009 11:55:13 PM
STKH Stockhouse, Inc. 33 09/05/2008 11:01:13 AM
TMWD Tumbleweed Communications Corp. 10 06/06/2008 09:55:42 AM
RNWK RealNetworks 10 05/09/2008 10:25:47 AM
DHX Dice Holdings, Inc. 1 11/16/2007 12:23:28 AM
PTRN Patron Systems 14 04/25/2007 06:48:14 AM
CNTE California News Tech 4 08/21/2006 04:30:44 PM
AOLA AOL Latin America 8 04/12/2005 08:57:27 PM
YDIW WIFI and stuff.... 1 07/23/2003 12:06:03 AM
KOOP drkoop.com Inc. 13 07/09/2001 09:52:54 AM
VDAT Visual Data Corporation 8 05/15/2001 12:34:05 AM

INTERNET INFORMATION PROVIDERS
I'm sure this list needs to be updated... There are many more not listed here
http://biz.yahoo.com/ic/851.html
Industry Top Performers
Intraday Price Performance % Change Market Cap
Akamai Technologies, Inc. [AKAM] +18.60% $4.8 B
Jiayuan.com International Ltd. [DATE] +11.81% $180.1 M
Shutterfly, Inc. [SFLY] +9.04% $798.1 M
Yandex N.V. [YNDX] +6.49% $5.8 B
ChinaCache International Holdin [CCIH] +4.83% $94.1 M

More Top Intraday Price Performers...
Market Capitalization % Change Market Cap
Google Inc. [GOOG] +0.62% $202.7 B
WILLIAM HILL [WMH.L] +0.42% $131.9 B
Baidu, Inc. [BIDU] +2.29% $39.4 B
INFO EDGE [NAUKRI.BO] -1.42% $31.4 B
Groupon, Inc. [GRPN] -3.75% $14.6 B

INDUSTRY CENTER - INTERNET INFORMATION PROVIDERS NEWS
http://biz.yahoo.com/ic/news/851.html

I think Equities.com will be added to this list shortly GBTR

http://investorshub.advfn.com/boards/boards.aspx?cat_id=37

[ICEQUITY]

CRWG CrowdGather, Inc. is a Equities.com client correct?

Thats good because Globetrac Due Diligence has been complete with Equities.com... Reverse Merger moving forward within 7-10 days.

Equities.com being a public company will bring more attention to 'CrowdGather, Inc. (CRWG)' -IMO

http://www.equities.com/summary?s=CRWG

[ICEQUITY]

Expect Us! I still believe in Equity for Equities.

If only our government gave everyone in the United States a $2000 online trading account... Instead of giving the $700B+ to the banks to plunder, we would all be in a much better place. This is the information age... Transparency Will Set You Free. Remember the .coms of the early 2000's, get ready for one hell of a come back. They were not quite ready then... But they are now, forward looking financial statements takes the back seat to a Enjoyable User Experience. Ask Facebook... Ha! Any company in this sector "Internet Information Providers" would be happy with 1% of FB's current value? $100B? Maybe except for Google LOL http://bit.ly/TimeOnSite

http://biz.yahoo.com/ic/851.html FB's Statistics
Penetration of population: 50.74%
Penetration of online population 65.80%
Average CPC: $0.82
Average CPM: $0.35
http://www.socialbakers.com/facebook-statistics - Equities.com "Social Network for the Global Investment Community" Where members are always free... The (1%) are the ones that pay!

Find your Financial Freedom in Equities

Expect Us!

[ICEQUITY]

OTCBB System Changes - 12/16/2011 12:00:00 AM

OTCBB Daily List
Other-OTC / Portal / PPS Daily List
OTCBB, Other-OTC and Portal Daily List
SECURITY ADDITIONS
Updated Symbol Company Name Effective Date OATS
Reportable
Flag Unit of
Trade Comments
15:31 VNGE Vanguard Energy Corporation Common Stock 12/19/2011 Y 100
15:31 VNGEW Vanguard Energy Corporation Class A Warrants 12/19/2011 Y 100
SECURITY DELETIONS
Updated Symbol Company Name Effective Date Unit of
Trade Comments
07:55 BCLX Big Clix Corp. Common 12/16/2011 100 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
07:55 BLES Blue Sun Media, Inc. Common 12/16/2011 100 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
07:55 BLFL BlueFlash Communications, Inc. Common 12/16/2011 100 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
07:55 BSKS Bluesky Systems Holdings, Inc. Common Stock 12/16/2011 100 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
07:55 EEDG Energy Edge Technologies Corporation Common 12/16/2011 100 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
07:55 MLGT mLight Tech, Inc. Common 12/16/2011 100 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
07:55 NFDS New Found Shrimp, Inc. Common 12/16/2011 100 Ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11
13:10 CNDO Coronado Biosciences, Inc. Common 12/19/2011 100 Listed on NCM (CNDO)**
15:31 VNGEU Vanguard Energy Corporation UNIT 1 COM & 1 CL A WT 12/19/2011 100 Seperation of Units **
NAME/SYMBOL CHANGES
Updated Date Old Symbol Old Name New Symbol New Name Comment
13:10 12/19/2011 IDOI IDO Security Inc. Common Stock IDOID IDO Security Inc. NEW Common Stock 1-3,000 R/S **

http://www.otcbb.com/asp/dailylist_detail.asp?d=12/16/2011&mkt_ctg=OTCBB

[ICEQUITY]

BSKS Rule 15c2-11 -- Initiation or Resumption of Quotations without Specified Information

Preliminary Note:

Brokers and dealers may wish to refer to Securities Exchange Act Release No. 29094 (April 17, 1991), for a discussion of procedures for gathering and reviewing the information required by this rule and the requirement that a broker or dealer have a reasonable basis for believing that the information is accurate and obtained from reliable sources.
As a means reasonably designed to prevent fraudulent, deceptive, or manipulative acts or practices, it shall be unlawful for a broker or dealer to publish any quotation for a security or, directly or indirectly, to submit any such quotation for publication, in any quotation medium (as defined in this section) unless such broker or dealer has in its records the documents and information required by this paragraph (for purposes of this section, "paragraph (a) information"), and, based upon a review of the paragraph (a) information together with any other documents and information required by paragraph (b) of this section, has a reasonable basis under the circumstances for believing that the paragraph (a) information is accurate in all material respects, and that the sources of the paragraph (a) information are reliable. The information required pursuant to this paragraph is:

A copy of the prospectus specified by Section 10(a) of the Securities Act of 1933 for an issuer that has filed a registration statement under the Securities Act of 1933, other than a registration statement on Form F-6, which became effective less than 90 calendar days prior to the day on which such broker or dealer publishes or submits the quotation to the quotation medium, Provided That such registration statement has not thereafter been the subject of a stop order which is still in effect when the quotation is published or submitted; or
A copy of the offering circular provided for under Regulation A under the Securities Act of 1933 for an issuer that has filed a notification under Regulation A and was authorized to commence the offering less than 40 calendar days prior to the day on which such broker or dealer publishes or submits the quotation to the quotation medium, Provided That the offering circular provided for under Regulation A has not thereafter become the subject of a suspension order which is still in effect when the quotation is published or submitted; or

A copy of the issuer's most recent annual report filed pursuant to Section 13 or 15(d) of the Act or a copy of the annual statement referred to in Section 12(g)(2)(G)(i) of the Act, in the case of an issuer required to file reports pursuant to Section 13 or 15(d) of the Act or an issuer of a security covered by Section 12(g)(2)(B) or (G) of the Act, together with any quarterly and current reports that have been filed under the provisions of the Act by the issuer after such annual report or annual statement; Provided, however, That until such issuer has filed its first annual report pursuant to Section 13 or 15(d) of the Act or annual statement referred to in Section 12(g)(2)(G)(i) of the Act, the broker or dealer has in its records a copy of the prospectus specified by Section 10(a) of the Securities Act of 1933 included in a registration statement filed by the issuer under the Securities Act of 1933, other than a registration statement on Form F-6, that became effective within the prior 16 months, or a copy of any registration statement filed by the issuer under Section 12 of the Act that became effective within the prior 16 months, together with any quarterly and current reports filed thereafter under Section 13 or 15(d) of the Act; and Provided further, That the broker or dealer has a reasonable basis under the circumstances for believing that the issuer is current in filing annual, quarterly, and current reports filed pursuant to Section 13 or 15(d) of the Act, or, in the case of an insurance company exempted from Section 12(g) of the Act by reason of Section 12(g)(2)(G) thereof, the annual statement referred to in Section 12(g)(2)(G)(i) of the Act; or

The information that, since the beginning of its last fiscal year, the issuer has published pursuant to Rule 240.12g3-2(b), and which the broker or dealer shall make reasonably available upon the request of a person expressing an interest in a proposed transaction in the issuer's security with the broker or dealer, such as by providing the requesting person with appropriate instructions regarding how to obtain the information electronically; or
The following information, which shall be reasonably current in relation to the day the quotation is submitted and which the broker or dealer shall make reasonably available upon request to any person expressing an interest in a proposed transaction in the security with such broker or dealer:

the exact name of the issuer and its predecessor (if any);

the address of its principal executive offices;

the state of incorporation, if it is a corporation;

the exact title and class of the security;

the par or stated value of the security;

the number of shares or total amount of the securities outstanding as of the end of the issuer's most recent fiscal year;

the name and address of the transfer agent;

the nature of the issuer's business;

the nature of products or services offered;

the nature and extent of the issuer's facilities;

the name of the chief executive officer and members of the board of directors;

the issuer's most recent balance sheet and profit and loss and retained earnings statements;

similar financial information for such part of the 2 preceding fiscal years as the issuer or its predecessor has been in existence;

whether the broker or dealer or any associated person is affiliated, directly or indirectly with the issuer;

whether the quotation is being published or submitted on behalf of any other broker or dealer, and, if so, the name of such broker or dealer; and

whether the quotation is being submitted or published directly or indirectly on behalf of the issuer, or any director, officer or any person, directly or indirectly the beneficial owner of more than 10 percent of the outstanding units or shares of any equity security of the issuer, and, if so, the name of such person, and the basis for any exemption under the federal securities laws for any sales of such securities on behalf of such person.

If such information is made available to others upon request pursuant to this paragraph, such delivery, unless otherwise represented, shall not constitute a representation by such broker or dealer that such information is accurate, but shall constitute a representation by such broker or dealer that the information is reasonably current in relation to the day the quotation is submitted, that the broker or dealer has a reasonable basis under the circumstances for believing the information is accurate in all material respects, and that the information was obtained from sources which the broker or dealer has a reasonable basis for believing are reliable. This paragraph (a)(5) shall not apply to any security of an issuer included in paragraph (a)(3) of this Section unless a report or statement of such issuer described in paragraph (a)(3) of this Section is not reasonably available to the broker or dealer. A report or statement of an issuer described in paragraph (a)(3) of this Section shall be "reasonably available" when such report or statement is filed with the Commission.

With respect to any security the quotation of which is within the provisions of this Section, the broker or dealer submitting or publishing such quotation shall have in its records the following documents and information:

A record of the circumstances involved in the submission of publication of such quotation, including the identity of the person or persons for whom the quotation is being submitted or published and any information regarding the transactions provided to the broker or dealer by such person or persons;

A copy of any trading suspension order issued by the Commission pursuant to Section 12(k) of the Act respecting any securities of the issuer or its predecessor (if any) during the 12 months preceding the date of the publication or submission of the quotation, or a copy of the public release issued by the Commission announcing such trading suspension order; and

A copy or a written record of any other material information (including adverse information) regarding the issuer which comes to the broker's or dealer's knowledge or possession before the publication or submission of the quotation.

The broker or dealer shall preserve the documents and information required under paragraphs (a) and (b) of this Section for a period of not less than three years, the first two years in an easily accessible place.

For any security of an issuer included in paragraph (a)(5) of this Section, the broker or dealer submitting the quotation shall furnish to the interdealer quotation system (as defined in paragraph (e)(2) of this Section), in such form as such system shall prescribe, at least 3 business days before the quotation is published or submitted, the information regarding the security and the issuer which such broker or dealer is required to maintain pursuant to said paragraph (a)(5) of this Section.

For any security of an issuer included in paragraph (a)(3) of this Section,

a broker-dealer shall be in compliance with the requirement to obtain current reports filed by the issuer if the broker-dealer obtains all current reports filed with the Commission by the issuer as of a date up to five business days in advance of the earlier of the date of submission of the quotation to the quotation medium and the date of submission of the paragraph (a) information pursuant to Schedule H of the By-Laws of the National Association of Securities Dealers, Inc.; and

a broker-dealer shall be in compliance with the requirement to obtain the annual, quarterly, and current reports filed by the issuer, if the broker-dealer has made arrangements to receive all such reports when filed by the issuer and it has regularly received reports from the issuer on a timely basis, unless the broker-dealer has a reasonable basis under the circumstances for believing that the issuer has failed to file a required report or has filed a report but has not sent it to the broker-dealer.

For purposes of this Section:

"Quotation medium" shall mean any "interdealer quotation system" or any publication or electronic communications network or other device which is used by brokers or dealers to make known to others their interest in transactions in any security, including offers to buy or sell at a stated price or otherwise, or invitations of offers to buy or sell.

"inter-dealer quotation system" shall mean any system of general circulation to brokers or dealers which regularly disseminates quotations of identified brokers or dealers.

Except as otherwise specified in this rule, "quotation" shall mean any bid or offer at a specified price with respect to a security, or any indication of interest by a broker or dealer in receiving bids or offers from others for a security, or any indication by a broker or dealer that he wishes to advertise his general interest in buying or selling a particular security.

"Issuer", in the case of quotations for American Depositary Receipts, shall mean the issuer of the deposited shares represented by such American Depositary Receipts.

The provisions of this Section shall not apply to:

The publication or submission of a quotation respecting a security admitted to trading on a national securities exchange and which is traded on such an exchange on the same day as, or on the business day next preceding, the day the quotation is published or submitted.

The publication or submission by a broker or dealer, solely on behalf of a customer (other than a person acting as or for a dealer), of a quotation that represents the customer's indication of interest and does not involve the solicitation of the customer's interest; Provided, however, That this paragraph (f)(2) shall not apply to a quotation consisting of both a bid and an offer, each of which is at a specified price, unless the quotation medium specifically identifies the quotation as representing such an unsolicited customer interest.



The publication or submission, in an interdealer quotation system that specifically identifies as such unsolicited customer indications of interest of the kind described in paragraph (f)(2) of this Section, of a quotation respecting a security which has been the subject of quotations (exclusive of any identified customer interests) in such a system on each of at least 12 days within the previous 30 calendar days, with no more than 4 business days in succession without a quotation; or

The publication or submission, in an interdealer quotation system that does not so identify any such unsolicited customer indications of interest, of a quotation respecting a security which has been the subject of both bid and ask quotations in an interdealer quotation system at specified prices on each of at least 12 days within the previous 30 calendar days, with no more than 4 business days in succession without such a two-way quotation;

A dealer acting in the capacity of market maker, as defined in Section 3(a)(38) of the Act, that has published or submitted a quotation respecting a security in an interdealer quotation system and such quotation has qualified for an exception provided in this paragraph (f)(3), may continue to publish or submit quotations for such security in the interdealer quotation system without compliance with this Section unless and until such dealer ceases to submit or publish a quotation or ceases to act in the capacity of market maker respecting such security.

The publication or submission of a quotation respecting a municipal security.

(5) The publication or submission of a quotation respecting a Nasdaq security (as defined in Rule 242.600 of this chapter), and such security's listing is not suspended, terminated, or prohibited.

The requirement in subparagraph (a)(5) that the information with respect to the issuer be "reasonably current" will be presumed to be satisfied, unless the broker or dealer has information to the contrary, if:

The balance sheet is as of a date less than 16 months before the publication or submission of the quotation, the statements of profit and loss and retained earnings are for the 12 months preceding the date of such balance sheet, and if such balance sheet is not as of a date less than 6 months before the publication or submission of the quotation, it shall be accompanied by additional statements of profit and loss and retained earnings for the period from the date of such balance sheet to a date less than 6 months before the publication or submission of the quotation.

Other information regarding the issuer specified in subparagraph (a)(5) is as of a date within 12 months prior to the publication or submission of the quotation.

This Section shall not prohibit any publication or submission of any quotation if the Commission, upon written request or upon its own motion, exempts such quotation either unconditionally or on specified terms and conditions, as not constituting a fraudulent, manipulative or deceptive practice comprehended within the purpose of this Rule.

http://taft.law.uc.edu/CCL/34ActRls/rule15c2-11.html

[ICEQUITY]

CrowdGather, Inc. CRWG
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=70026694

[ICEQUITY]

RIGH has better numbers then CANA aka Weedmaps http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69862341
budgenius vs weedmaps... budgenius wins hands down!

[SevenTenEleven]

CBIS - Cannabis Science (OTCBB: CBIS) Expanding West Into California

Cannabis Science (OTCBB:CBIS)

Today : Thursday 15 December 2011


Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, has announced it has entered final negotiations to bring Cannabis Science brand of pharmaceutical products into California.
The medical marijuana industry is worth approximately $1.7 billion this year and could reach almost $9 billion by 2016. Currently, California and Colorado dominate the nascent industry, representing 92% of all wholesale and retail sales across the country. With nine states and the District of Columbia currently with medical marijuana laws, there are a potential 24.8 million potential patients.

Cannabis Science aims to create cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Other active stocks are Powertec International (OTCBB: POWT), Sauer Energy, Inc (OTCBB: SENY) and Capstone Infrastructure Corp (PINKSHEETS: MCQPF)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO Circuit twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact:

IO Circuit

[ICEQUITY]

GBTR 12/20/11 should be a interesting day - IMO
12-Month 0.6200 on 06/16/2011 0.0010 on 12/20/2010 +9.00% since 12/07/2010
http://www.barchart.com/detailedquote/stocks/GBTR

CIK 0001143238
Fiscal Year End 12/31
OTC Market Tier OTCQB

http://www.otcmarkets.com/stock/GBTR/company-info


http://shortvolume.com/



GBTR Charts have not looked this good for a while!

I'm thinking it would be in GBTR and Equities best interest to make this happen before the New Year... For Financial Reporting & Tax Reasons...

Don't you agree?

[SevenTenEleven]

HEMP - Marijuana, Inc. (HEMP.PK) Supports "The Cash Hyde Fund for Cancer Awareness" as Its TV Division Films Recent Fund Raising Eve...

Marijuana (PN) (USOTC:HEMP)

Today : Tuesday 13 December 2011


Marijuana, Inc. (PINKSHEETS: HEMP) is proud to announce the first event covered by MarijuanaIncTV LIVE as its film crew documented The Art of Mary Jane Magazine/Cash Hyde Foundation well attended Fundraiser held at actor and filmmaker Sean Cook's Bel Air, California estate, on Saturday, Dec. 10, 2011.
In depth coverage of the event will be made available at www.marijuanainc.tv (site under construction). Industry insiders, notably actor and comedian Tommy Chong, arrived from across the country to embrace and contribute to the cause of the nation's youngest medical marijuana patient, Cash Hyde, who was diagnosed with stage 4 brain cancer when he was only two years old.

Cash, now four, has responded well to a cannabis protocol designed to help ease recovery from ongoing radiation treatments, a scenario where traditional medicines had been ineffective. The Hyde family decided on the use of cannabis for their child after weeks of watching his body failing.

Father Mike Hyde stated that the cannabis protocol has dramatically improved Cash's ability to eat, sleep and regain bodily function. Marijuana Inc.'s philanthropic commitment to the Cash Hyde Fund for Cancer Awareness was emphasized by a Platinum level donation to the event, and continues following an initial stock donation, with ongoing monthly donations through the calendar year of 2012.

Marijuana, Inc.'s contribution did not end with the stock donation; they also gifted over 100 "King of Pot" half ounce silver commemorative coins for attendees' gift bags. Marijuana, Inc.'s CEO, Bruce Perlowin, stated, "We wanted to help make the event a success not only for Cashy but to bring awareness of the benefits of medical marijuana to cancer patients nationwide. We put people first -- profits second as our corporate culture, and by leading by example we can make a difference. Through our friends, The Art of Mary Jane Magazine, Tommy Chong, Sean Cook and everyone who took the time to attend and participate in the silent auction at the event, we brought new attention and funding for Cash's fight for life."

For more information on the Cash Hyde Fund for Cancer Awareness, The Art of Mary Jane Magazine and the Cash Hyde event, please see the following links: http://www.cashhydefoundation.com, www.maryjaneevents.com, http://www.ktvq.com/news/cancer-returns-to-cash-hyde

ABOUT MARIJUANA, INC.

Marijuana, Inc.'s (PINKSHEETS: HEMP) focus is on the peripheral businesses created by the quickly emerging, and growing, multibillion dollar medical marijuana and hemp industries. Marijuana, Inc. (PINKSHEETS: HEMP) is not involved in the cultivation or marketing of medical marijuana. It is the company's belief that legalization on a federal level will one day occur for all 50 states. With that in mind, the company's infrastructure is building, with the potential to gain substantial market share once that occurs. (Pending any federal licensing or other requirements, that may be enacted after marijuana prohibition ends).

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Marijuana, Inc. to be materially different from the statements made herein.

FOR FUTHER INFORMATION ON MARIJUANA, INC. (HEMP.PK) SEE:



www.marijuanainc.tv

www.Kushclear.com

www.ecoharmonycard.com

www.BrucePerlowin.com

(sites under construction)



TO CONTACT MARIJUANA, INC.:

[e-mail]

[phone]

[ICEQUITY]

Short Interest RIGH today - 51,296,551

Learn more about short interest here
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69831385

20111212|RIGH|51296551|0|191862078|O

For full list look here
http://regsho.finra.org/FORFshvol20111212.txt

[SevenTenEleven]

MWIP - MediSwipe Inc. Announces Launch of Mobile Payment and Loyalty Solution to Rx Pharmacies, Wellness Centers and Retail Merchants

Mediswipe (OTCBB:MWIP)

Today : Monday 12 December 2011


MediSwipe Inc. (www.MediSwipe.com) (OTCBB:MWIP), a merchant payment solutions and financial products company for the medical health care industry, and its wholly owned subsidiary 800 Commerce Inc. (www.800Commerce.com), a leading enabler and turnkey e-commerce solution provider including mobile payment solutions, today announced that the Company has launched sales of its mobile payment and loyalty solution for Rx Pharmacies, wellness centers and retail merchants thoughout selected areas of the United States. Through its previously announced agreement with SparkBase and the use of the mobile payment PayCloud application, MediSwipe clients will now be migrated to the new mobile payment system offering a next generation form of payment for prescriptions, goods and services as an alternative to traditional credit card purchases and cash transactions.
Once the free PayCloud application is downloaded via the iTunes or Android stores online by the customer, they will then have access to all merchant locations via a geographical locator and map, showing all participating merchants on the system and network. The client or patient will need to register with a specific location, receive a branded loyalty and payment card and fund the card under traditional means. Once enrolled, after the first transaction, the customer may use a mobile smart phone device for transactions going forward using a mobile "e-wallet", and have complete access to all transactions going forward through our white label portal.

From the merchant side, for those seeking to enroll in the program, a specialized sensor is placed on any existing credit card terminal. Once the PayCloud software is downloaded to the terminal and the merchant is enrolled in our network, the location will appear in the geographic locator on the PayCloud application to thousands of new potential clients. Our white label branded card system allows for easy enrollment of existing and new clients extending the merchant brand with your logo on the card. Further, through a special audio transmission between the smart phone and terminal, customers may use their mobile phone to complete financial transactions without the use of any card present, and allowing the merchant to offer loyalty push programs to the mobile users similar to Groupon or Living Social for goods and services once enrolled in the network, creating store loyalty and building a strong customer database.

"We are anticipating tremendous response from this mobile payment and loyalty solution through our partnership with PayCloud. Already we are in negotiations to move thousands of patients for several pharmacies onto the system. We are also in the process of migrating our existing client base onto this sytem after the first of the year. We believe this next generation form of payment will allow MediSwipe to stay ahead of the technology curve and deal with the limitation issues presently involved with traditional credit card and cash transactions. Our revenue model for the system will involve a monthly gateway fee to merchants and a transaction fee of approximately .10 cents each time a purchase takes place. Those merchants interested in more information on the mobile payment and loyalty solution for their business should contact us at 615.252.4099," stated Michael Friedman, CEO of MediSwipe Inc.

About MediSwipe Inc.

MediSwipe Inc. (www.MediSwipe.com) offers a full spectrum of secure and reliable transaction processing and security solutions for the medical and healthcare industries, using traditional, Internet Point-of-Sale (POS), e-commerce and mobile (wireless) payment solutions. The Company now also offers digitized personal health records in conjunction with Industry Alliance Partners. MediSwipe offers reliable merchant payment solutions and closed loop pre-paid stored value and loyalty cards as a unique cash alternative to these regulated and e-commerce businesses specializing within the healthcare sector.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.

CONTACT: MediSwipe Inc.
Investor Relations:
615.252.4099
[e-mail]
[e-mail]

[SevenTenEleven]

CBIS - Second Self Medicated Medical Cannabis Cancer Patient Reports Cannabis Science Brand Extracts Killing Cancer Cells

Cannabis Science (OTCBB:CBIS)

Today : Monday 12 December 2011


Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to announce a second patient suffering skin cancer is self-administering cannabis extracts in collaboration with Cannabis Science. This patient has photo-documented dramatic results that we will be release to the public once treatment is completed and has been properly vetted by clinical biopsy. Cannabis Science, in conjunction with several Colorado-licensed dispensaries and physicians, consults with a number of cancer patients who were seeking to inform themselves of the current peer-reviewed scientific literature, regarding modern and historical use of cannabis preparations for treating cancers so that they can make informed decisions regarding their self-directed cancer treatment.

Cannabis has an outstanding safety profile as determined in 1988 by Federal Administrative Law Judge Francis Young who recommended cannabis be removed from Schedule I. The refusal of the DEA to follow this recommendation has resulted in 16 states allowing some form of medical marijuana access for their citizens. Numerous other states are moving in this direction. Consequently, patients in states with medical marijuana laws are able to make an informed decisions to try various state-legal cannabis preparations and to determine what is most effective for their particular condition. As a result, there is an unprecedented accumulation of “anecdotal” data

Currently, there are a variety treatments available for treating various skin cancers including standard surgical excision (Mohs Surgery), chemotherapy, radiation, and cryosurgery. Unfortunately for many, the cancer frequently returns and requires additional treatments. Chemo and radiation therapy are typically used by patients who aren’t candidates for surgery (i.e. where surgical excision could disfigure or make it difficult to reconstruct the excised area). If reoccurrence occurs, radiation therapy is often not repeated as it may further damage the tissue lead to resistance.

While the above treatments may to be effective for many, few patients would choose to go through surgical procedures, radiation, or chemotherapy if a better alternative were available. Patients self-administering cannabis extracts in the convenience of their own home appear to be effectively resolving their cancerous lesions over a period of a few weeks to a few months.

Cannabis Science is committed to making cannabis-based medicines available to the public as rapidly as possible. The Company is taking multiple approaches to accomplishing this aim in the United States. The science of cannabinoids has exploded over the past decade, laying the scientific foundation for the many medicinal uses of this unique plant. Cannabinoids are a class of biologically active compounds produced by all vertebrates (endocannabinoids) the Cannabis plant (phytocannabinoids), and more recently patentable synthetic compounds produced by chemists. Today’s modern peer-reviewed science supports the many historical uses that were discovered over thousands of years of medicinal use by herbalists.

Please visit www.cannabisscience.com to view the “Breaking News” of the successful results and images of the self-administered cancer treatments.

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

[ICEQUITY]

Compare Equities.com members Time on Site (minutes) to IHub, Yahoo Finance & Google Finance!
http://www.alexa.com/siteinfo/equities.com#


Do you think Equities.com Time on Site will be an Advantage for Issuers who choose to advertise on Equities.com?

If one user of the site can get this much traffic to a blog... Can you imagine what a couple more members can do?
https://bitly.com/DTCC86+

Thanks for your post, but I think the freedom for ideas... Is one of their greatest assets.
"All Glory Is Fleeting" Not on My Quadriga
http://www.equities.com/blogs/stocknotifier-0

Want to take charge of your finances, do you consider yourself a self directed investor?

Do you really want to go down this rabbit hole?
Derivatives: A $700+ Trillion Bubble Waiting to Burst
http://seekingalpha.com/article/131597-derivatives-a-700-trillion-bubble-waiting-to-burst

Then I think it is up to each and everyone of us to do want we can do... Even if it is in the smallest measures... IMO - Take the blue pill.

http://ih.advfn.com/videos/just-for-fun/catch-this-wave-gbtr-i-see-equity_EL19vw3P6QE

Analytics is where it is at... They speak louder then words... When GBTR and Equities.com complete this deal, you will see it will empower Equities.com to scale up for The Global Investment Community.

I See Equity in Equities!

[ICEQUITY]

Really are you watching GBTR? Watch this!

"Catch This Wave GBTR" http://ih.advfn.com/videos/just-for-fun/catch-this-wave-gbtr-i-see-equity_EL19vw3P6QE

Simple Video... But I think it can be very Effective!

[SevenTenEleven]

HEMP - Marijuana, Inc. Announces, and Launches, New "KushClear™" Nutraceutical Hemp Based Product Lines.

Marijuana (PN) (USOTC:HEMP)

Today : Thursday 8 December 2011


Marijuana, Inc. (OTC: HEMP.PK) - announces the roll-out of their new KushClear™ line of private labeled wellness products. Developed over the last two years specifically for the Medical Marijuana community, KushClear™ products are designed to target specific needs with 100% natural ingredients, for anyone desirous of alternative health care modalities.

Initially, four products will be available with the premier product being a Hemp Protein mix with Spirulina, AFA blue-green algae, Cordyceps, and Rhodiola Rosea. The three additional products currently available are KushClear™ Male for immediate male enhancement, KushClear™ Male for Daily Use for long term male enhancement, and KushClear™ Desire for female enhancement. For more information, or ordering products, go to: www.kushclear.com.

All products are further enhanced with the Agronifier™ technology that uses a combination of electromagnetic and sound waves to increase their efficacy. This patent pending process is licensed from Ferris Holding, Inc. the developer of the Agronifier™. For more details go to (www.ferrisholding.com)

Bruce Perlowin, CEO of Marijuana, Inc, stated, "It was important to us to deliver a line of healthy nutraceuticals that would stand out in a crowded industry. Annually people spend hundreds of dollars on products which claim to work but don't, simply because they do not deliver enough active ingredients to do the job."

The KushClear™ line of products offer three unique benefits: They are either liquid or powder that is added to a liquid, this form of delivery is much more efficient than tablets or capsules that can pass through the body without dissolving. They contain enough of the effective ingredients to get the results a person expects. They are further enhanced with the healthy Agronifier™ technology, increasing the overall effectiveness of the products."

David Tobias, President of Marijuana, Inc. stated, "In addition to our initial KushClear™ product line we are in the final phases of rolling out an entire line of hemp based cosmetic, skin care and personal care products for release in January of 2012."

ABOUT MARIJUANA, INC.

Marijuana, Inc. (HEMP.pk) intends to focus on the huge peripheral businesses created by the quickly emerging, and growing, multibillion dollar medical marijuana and hemp industries.

Marijuana, Inc. (HEMP.pk) will not be involved at the current time in growing, transporting or marketing medical marijuana itself – however it will be creating an infrastructure to do parts of this upon the company's belief that legalization on a federal level will one day occur for all 50 states (pending any federal licensing or other requirements that may be enacted after marijuana prohibition ends).

CEO, Bruce Perlowin also stated, "One of our goals is to help provide the business tools, technologies and mind set to help incorporate the emerging medical marijuana industry into mainstream commerce that it is destined to be. From education and training, to creating unique and advanced technologies applicable to this arena, as well as other industries." www.marijuanainc.tv (still under construction).

President David Tobias also stated, "We are all now at the right place at the right time, with the right experience, to take advantage of an industry that has been around for thousands of years and rapidly emerging into mainstream countries as a new economic force in dozens of areas. Over the past few years it has become apparent that with the increasing pace of new products and services hitting the marketplace that this industry provides unique opportunities for a vast array of business ventures. With 10 states voting in November 2012 on cannabis, medical cannabis and hemp laws we are preparing now for the future of marijuana and hemp in America and worldwide."

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Marijuana, Inc. to be materially different from the statements made herein.

FOR FUTHER INFORMATION ON MARIJUANA, INC. (HEMP.PK) SEE: www.marijuanainc.tv, www.Kushclear.com, www.ecoharmonycard.com, www.BrucePerlowin.com (sites under construction)

TO CONTACT MARIJUNANA, INC.: [e-mail], [phone] News Re-release and Updated from October 27, 2011 For Those That Missed It The First Time.

SOURCE Marijuana, Inc.

[ICEQUITY]

BEST MM GBTR DD EVER
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69673079

[SevenTenEleven]

The other one to watch IMO, is MCUJ. Not for a squeeze play. Well, at least not yet.

If there was 24MM in volume for MCUJ, the PPS would go from $0.02 to a buck.

[SevenTenEleven]

I am watching GBTR :)

[ICEQUITY]

Do you know what would happen if GBTR had this volume right now?

2011/12/06 0.30 0.54 0.30 0.40 36,950,437 0.40
2011/12/05 0.26 0.29 0.25 0.29 17,204,838 0.29
2011/12/02 0.23 0.27 0.23 0.25 15,065,169 0.25
2011/12/01 0.23 0.24 0.19 0.22 19,727,026 0.22
2011/11/30 0.18 0.23 0.18 0.23 16,443,074 0.23

Amwest Imaging.... Amwest who?

Thats kids play... You aint seen nothing yet... GBTR

[SevenTenEleven]

Nice little SQUEEZE over at AMWI! Looks a lot like LEXG!

[ICEQUITY]

Thats dope!


What do you think if I turn this board into a IREQUITIES? Specializing in Cannabis stocks? Any Boards Still Active... Like that?

[SevenTenEleven]

RIGH - echnologies Merge to Further Transform the Medical Cannabis Market

PR Newswire

BOCA RATON, Fla., Dec. 7, 2011

BOCA RATON, Fla., Dec. 7, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC: RIGH.PK) is pleased to announce the details of its pending Reverse Merger, to be completed later this month, … [RM info] … with BG Medical Technologies, Inc., an industry leader in medical cannabis laboratory analysis, and developer of popular medical cannabis website www.BudGenius.com.

BudGenius.com currently services the medical cannabis market utilizing a proprietary software engine that assists in predicting the medicinal effects of cannabis strains through a combination of laboratory chromatography analysis and patient response data received through its social media portal. Research results are displayed upon on the BudGenius.com website, and also within participating cannabis dispensaries, to assist patients in selecting cannabis strains that address their intended medical needs.

"We find this merger of science and social media to be quite remarkable," stated CEO Angel Stanz. "Today we are producing first looks into cannabinoid ratio effects, which has been facilitated by laboratory work and social media. In the near future we expect to correlate these findings to better support doctors in recommending specific strains for treatments in cancer, Parkinson's disease, Alzheimer's, and more. Cannabis is just the beginning. We strongly believe this matching of science and social media is a blueprint for improving the efficacy of many alternative therapies."

BudGenius entered the medical cannabis industry as a pioneer in medical marijuana testing by providing the first online laboratory-tested strain database for patient and medical professionals. BudGenius continues to deliver industry-leading services, and maintains the largest online photographic database of tested cannabis medicine worldwide, obtained from over 230 independent sources within California. BudGenius.com is the most visited online portal for cannabis testing services.

"This [merger with RightSmile] provides BudGenius and BG Medical Technologies the resources to develop new levels of patient care for alternative medical treatments," explains Mr. Stanz. "In 2012, BG Medical will continue our innovations by introducing support tools for medical care professionals, additional business tools for dispensaries, and interactive educational media content for patients. These features will be HIPAA-compliant, where applicable, and mobile app-enabled for patient convenience. "

The breakthrough services BudGenius currently provides are powered by the combination of science, social media, and software development. Every cannabis plant represents a unique set of therapeutic characteristics based upon its genetics and growing environment. Each harvest is analyzed to determine its chemical composition and its safety for consumption. Patients receiving BudGenius tested medicine report on the efficacy of the experienced effects by utilizing the BudGenius.com social portal. These experiences are then mapped to the unique chemical ratios comprising the patient's cannabis strain. This produces a loosely controlled scientific trial of thousands of patients, all contributing data in real-time to BG Medical's server cloud. This information is then processed to extrapolate an ailment rating system for newly analyzed strains.

"We find this merger of science and social media to be quite remarkable," continues Mr. Stanz. "Today we are producing first looks into cannabinoid ratio effects, which has been facilitated by laboratory work and social media. In the near future we expect to correlate these findings to better support doctors in recommending specific strains for treatments in cancer, Parkinson's disease, Alzheimer's, and more. Cannabis is just the beginning. We strongly believe this matching of science and social media is a blueprint for improving the efficacy of many alternative therapies."

BudGenius derives its revenue through cannabis analysis services. New growth will include targeted advertising services, physician support systems, medicinal administration solutions, and software licensing. Legislation supporting medical cannabis continues to be introduced nationwide often including regulations mandating cannabis analysis services for patient safety concerns. BudGenius is meeting this [$x million market] demand through territory expansion and appropriate acquisitions.

About BG Medical Technologies, Inc.

BG Medical Technologies is a life sciences solution developer for alternative medical treatments headquartered in California. BG Medical Technologies owns and operates BudGenius.com, a social web laboratory providing medical cannabis safety and treatment analysis.

Legislation supporting medical cannabis continues to be introduced nationwide often including regulations mandating cannabis analysis services for patient safety concerns. BudGenius is meeting this demand through territory expansion and its cloud-based architecture for supporting multiple licensed laboratory locations. New areas of growth include Internet advertising revenue, physician support software, and diagnostic support tools.

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.



Contact:

Randy Schneider561-404-4895



SOURCE RightSmile, Inc.

[SevenTenEleven]

APHY - I am staying on top of company. Plan is still to get SEC current with 10K's and remain current and fully reporting. It is my understanding that from there, the uplisting will be addressed.

[ICEQUITY]

They need to get VIPPS certified... so they can advertise online with google

[ICEQUITY]

No Shiet... Thats cool... I still need to check out their pharmacy out here in LA

[SevenTenEleven]

APHY - Assured Pharmacy Opens Kansas City Location

Fifth Specialty Pharmacy Now Filling Prescriptions and Processing Patients


Press Release: Assured Pharmacy, Inc. – Thu, Dec 1, 2011 8:01 AM EST


FRISCO, Texas , Dec. 1, 2011 /PRNewswire/ -- Assured Pharmacy, Inc. (Pink Sheets:APHY.PK), a leading specialty pharmacy group providing prescription medications to more than 3,000 sufferers of chronic pain, announced that its fifth specialty pharmacy is now open for business. Located in the Kansas City metropolitan area, this location joins the Company's existing pharmacies in Santa Ana and Riverside, California ; Seattle, Washington ; and Portland, Oregon .

Robert DelVecchio , CEO of Assured Pharmacy, said, "The opening of our Kansas City store marks a major milestone in our growth strategy. The new pharmacy will benefit from the most recent enhancements to our business model, which utilizes past experience and best practices derived from the development of our other pharmacies. As a result of our historical experience and careful planning, the Kansas City pharmacy was opened on schedule and within our budget. We are excited to serve the needs of physicians and chronic pain patients in this region of the country."

The Kansas City pharmacy employs staff specifically trained to work with physicians' offices in the surrounding region to ensure that the prescription process for pain medications is handled in the ideal manner. Its services are designed to reduce doctors' exposure to liability triggered by fraudulent scripts of schedule II and III medications, and it also handles pre-authorization and verification issues.

About Assured Pharmacy, Inc.

Assured Pharmacy, Inc. is engaged in the business of providing specialty pharmacy services to patients and physicians in the treatment of chronic pain. The Company derives its revenue primarily from the sale of highly regulated prescription pain medications and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The majority of the Company's business is derived from repeat business from its customers. "Walk-in" prescriptions from physicians are limited. The Company currently has five operating pharmacies.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

The Investor Relations Group
11 Stone St. 3rd Floor
New York, NY
212-825-3210
IR: Erika Moran / Adam Holdsworth
or
PR: Janet Vasquez / Laura Colontrelle

http://finance.yahoo.com/news/Assured-Pharmacy-Opens-Kansas-prnews-2854440318.html?x=0

[ICEQUITY]

You are missing the point Jungle... like always. Ha! This is not about HESG, its about ALL stocks! The price is irrelevant, just set a sell order is the whole point.

I know this from first hand knowledge... And from a reliable shorter.

Oh, I've definitely learned some shady stuff. Why do you think I'm always so pessimistic?

Don't worry, I couldn't find any shares to short for this.

Enjoy~

If your shares do not have a sell order, they can be loaned out to be shorted. That is correct.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69659334


20111206|GBTR|4200|0|5600|O
http://regsho.finra.org/FORFshvol20111206.txt

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69673442

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69674157

I'm trying to do the right thing here... Pilgrim

Believe or Not Believe thats up to you... But like I said before, I would enjoy nothing more then seeing some familiar 420 friends around me...
Make Some Money$

Even you Jungle, you need to give the dog a bone sometime!

Yeah I speak with Tom.... He comes over every night to wash my dishes to try and make up my money I invested in HESG. Ha!


But realistically anything can happen with a shell corporation.


So remember my enthusiasm with HESG? Multiply that by x420 Million Million... And thats where I'm at! Lets go 420 TrilLion Traders... Are you with me or not?

Class is dismissed...

I See Equity in Equities - ICEQUITY
Investor in Life, Liberty and the pursuit of Happiness

[SevenTenEleven]

Shorty getting spanked on AMWI. Will HRNF be next? How about DHSM?

Time will tell!

Tic Toc NITE!

[ICEQUITY]

GBTR... Shorty wants to play! http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69638757

[ICEQUITY]

cifikea Shared TOP PROMOTED STOCKS BY MARKET FOR Dec 2011
Tuesday, December 06, 2011 9:06:59 AM
Re: None

Post # of 840
TOP PROMOTED STOCKS BY MARKET FOR Dec 2011
as of 12-6-2011
Pink Sheets Top 10
UHLN US HIGHLAND INC
PBGC PREMIER BEVERAGE
OMVE Omni Ventures, Inc.
REEI Ree International, Inc.
AERN AER ENERGY RESOURCES
BUCS BUSINESS CONT SOLUTN
ASKE Alaska Pacific Energy Corp.
RGNA Regeneca, Inc.
PSLRF Palliser Oil & Gas Corporation
XYTS XYTOS INC
OTC BB Top 10
WLOL Winland Ocean Shipping Corp
ECRY eCrypt Technologies, Inc.
BTHR Bella Petrella's Holdings, Inc.
ECIT ECOLAND INTL INC
ATTH ATLAS THERAPEUTICS
LSTG LONE STAR GOLD INC
EVGI ECO VENTURES GRP INC
AMWI Amwest Imaging Incorporated
SENY SAUER ENERGY, INC.
AHRO ATHERONOVA INC
NASDAQ Top 10
CDII China Direct Industries, Inc.
NXST Nexstar Broadcasting Group Inc.
PEIX Pacific Ethanol, Inc.
LOCM Local.com Corporation
TEAR TearLab Corporation
CLSN Celsion Corp.
CARV Carver Bancorp Inc.
LAVA Magma Design Automation Inc.
MITL Mitel Networks Corporation
LRAD LRAD Corporation
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69635402

[ICEQUITY]

NITE is looking for a fight... Ready to rumble?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69633283

[ICEQUITY]

I like it!! I think you will like this one... Let us Unite aGainst NITE

Let me show you some Light

"Remember that Money is of a prolific generating Nature..." B.F.
.25 will become a Dollar, then 1+1=2, 2+1=3, 2+3=5, 3+5=8...


GBTR
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69621499

Bro, Share this with your Brothers!
Peace!

[Nebuchadnezzar]

welcome back

[SevenTenEleven]

Glad to have you back! :)

Watching a few good ones.

Make sure you are keeping MCUJ on radar. From $0.02 it could easily move to $0.10 will very little volume. I am playing it at an average above $0.30. May move those set sells to higher levels if the right catalyst comes and begins to move the PPS.

Have seen other stocks move easily from $0.03 to well over $0.25, some even from $0.05 to well over $11 with less than what MCUJ has to offer as far as potential.

MCUJ is the most under valued stock I am currently following and holding.

Worth doing DD on ICE!

[ICEQUITY]

IM FREEEEEEEEEEE!!!!! Ah feels so good... Funny how some can run BSKS from the inside! Not speaking of myself of course... I'm just a slave holding the crown, for now...



http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69574869

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69569200

http://www.equities.com/blog/all-glory-fleeting-not-my-quadriga



All Glory Fleeting... Not on this board! Not on my Quadriga!


http://www.equitygroups.com/BSKS-discussion/BSKS--The-Health-Insurance-Portability-and-Accountability-Act-of-1996
The Health Insurance Portability and Accountability Act of 1996

The Administrative Simplification provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA, Title II) require the Department of Health and Human Services (HHS) to adopt national standards for electronic health care transactions and national identifiers for providers, health plans, and employers. To date, the implementation of HIPAA standards has increased the use of electronic data interchange. Provisions under the Affordable Care Act of 2010 will further these increases and include requirements to adopt:

• operating rules for each of the HIPAA covered transactions
• a unique, standard Health Plan Identifier (HPID)
• a standard and operating rules for electronic funds transfer (EFT) and electronic remittance advice (RA) and claims attachments.

In addition, health plans will be required to certify their compliance. The Act provides for substantial penalties for failures to certify or comply with the new standards and operating rules.

For more information regarding HIPAA including additional provisions under the Patient Protections and Affordable Care Act (Affordable Care Act or ACA) of 2010, go to the "Related Links Outside CMS".
HIPPA Information


Smart Cards Represent an Excellent Solution for HIPAA Compliance and Support New Applications That Improve Medical Care

The presence of processing capability and memory in a smart card, along with the smart card’s ability to support multiple applications, make smart cards an efficient and flexible mechanism that can help organizations achieve HIPAA compliance while meeting the goals of patients and practitioners. Smart cards have a unique ability to make information access easier for users while at the same time enforcing the more robust security policies required of health care organizations to bring their environments into HIPAA compliance. Smart cards can represent an excellent solution to an organization’s multiple physical and electronic security requirements. Systems that use smart cards as the identity token and secure data carrier have unique benefits.

Smart cards can provide easier information access management, ensuring that users are following established security policies.
Smart cards are a familiar form factor that can be used for both physical access to facilities and logical access to information on personal computers and networks.
Smart cards can help enforce access control to health information, providing support for both user authentication and encryption of data on the card and during transmission.
Smart cards can store health information on the card, performing as secure portable data carriers that are under the control of the patient and the health care professional.
Smart cards, with on-card intelligence and processing capabilities and the ability to use standards-based cryptography, are uniquely capable of enabling compliance with strong privacy guidelines and of enforcing the privacy and security policies set by the health care organization
Smart cards provide a feature-rich platform for health care organizations to implement new applications that improve access to and convenience of medical care.
Health care organizations worldwide are implementing smart health cards. With the appropriate security architecture, smart cards can be a very valuable tool to providers, insurers, and patients alike. They can be an instrumental component of any system that is designed to ensure compliance with HIPAA regulations, as well as supporting new applications that deliver clinical and administrative benefits.

About This Report

This report was developed by the Smart Card Alliance to describe how smart cards can be used to meet HIPAA Security Rule and Privacy Rule requirements. Designed as an educational overview for decision makers, it summarizes the HIPAA privacy and security requirements, provides an overview on how smart cards work, describes how smart cards can be used to support HIPAA compliance and implement other health care applications, and outlines key implementation success factors. The report also includes profiles of smart health card implementations including the University of Pittsburgh Medical Center, Mississippi Baptist Health Systems, and the French, German and Taiwanese health cards.

This report provides answers to commonly asked questions about the use of smart cards as health care cards, such as:

What requirements do the HIPAA Security Rule and Privacy Rule impose on health care providers, insurers, and patients?
How do smart cards work?
How can smart cards help health care organizations fulfill the HIPAA requirements?
What capabilities do smart cards provide for clinical and administrative benefits that extend beyond HIPAA requirements?
What can we learn from organizations who are currently using smart cards as health care cards?
What considerations are important to the successful implementation of a system that uses smart cards as health care cards?
If you would like to join the task force, please contact [e-mail].
Great Source of Information regarding Smart Cards


Smart Card with Biometrics = BSKS

Bluesky System Holding, Inc. (OTC:BB:BSKS), is the exclusive worldwide licensee of next generation secure data cards by reason of a certain License Agreement with Supera Group, LLC. ("Supera"). In connection with that Agreement, BSKS licensed more than 30 issued patents for the manufacture and sale of readers/writers and high-capacity data storage in a credit card format for the use in healthcare, and patient management, medical, dental and pharmaceutical records and other health applications. Bluesky expects the licensed technology to be a game changer in that the delivery of this next generation platform brings secured transactions into the modern world of technology that is being demanded by users.

[SevenTenEleven]

HEMP - Marijuana, Inc. (HEMP.pk) Funds and Brings to Market the Eco-Harmony Loyalty Card for Cultural Creatives Demonstrating Compas...

Marijuana (PN) (USOTC:HEMP)

Today : Friday 2 December 2011

Marijuana, Inc. (HEMP.pk) Funds and Brings to Market the Eco-Harmony Loyalty Card for Cultural Creatives Demonstrating Compassionate Capitalism
PR Newswire

LAS VEGAS, Dec. 2, 2011

LAS VEGAS, Dec. 2, 2011 /PRNewswire/ -- Marijuana, Inc. (OTC: HEMP) is proud to announce that after over two years in the development, and the funding - costing over $1.2 million dollars, it has completed the Eco-Harmony Loyalty Benefits and Rewards Card, targeting the cultural creative merchants and the cultural creative consumers from a wide variety of industries.

CEO, Bruce Perlowin stated, "I am particularly proud of the fact that the first product we created and launched into the marketplace, and has produced our first revenues, is one that not only earns income for our company and shareholders, it is designed to earn income as a fund raiser for our industries non-profits as well as other industries sympatric or similar to the medical marijuana movement. The economic model we will be endeavoring to follow in our company is called Compassionate Capitalism and this is an example of that."

ABOUT THE ECO-HARMONY LOYALTY BENEFITS AND REWARDS CARD

The Eco-Harmony Loyalty Card (www.ecoharmonycard.com still under construction) is the only card of its kind. It has the ability to track rewards for the card holder such as discounts, rebates, and daily deals, regardless of how the consumer pays – cash, check, credit card or debate card. On each qualified transaction a percentage of the rebates go back to the charity or non-profit of the card holder's choice; such as schools, churches, ecological organizations, and other social causes that are doing good deeds to better humanity and this planet.

ABOUT MARIJUANA, INC.

Marijuana, Inc. (HEMP.pk) intends to focus on the huge peripheral businesses created by the quickly emerging, and growing, multibillion dollar medical marijuana and hemp industries.

Marijuana, Inc. will not be involved at the current time in growing, transporting or marketing medical marijuana itself – however it will be creating an infrastructure to do parts of this upon the companies belief that legalization on a federal level will one day occur for all 50 states (pending any federal licensing or other requirements that may be enacted after marijuana prohibition ends).

CEO, Bruce Perlowin stated, "One of our goals is to help provide the business tools, technologies and mind set to help incorporate the emerging medical marijuana industry into mainstream commerce that it is destined to be. From education and training, to creating unique and advanced technologies applicable to this arena, as well as other industries." www.marijuanainc.tv (still under construction).

President David Tobias also stated "We are all now at the right place at the right time, with the right experience, to take advantage of an industry that has been around for thousands of years and rapidly emerging into mainstream countries as a new economic force in dozens of areas. Over the past few years it has become apparent that with the increasing pace of new products and services hitting the marketplace that this industry provides unique opportunities for a vast array of business ventures. With 12 states voting in November 2012 on cannabis, medical cannabis and hemp laws we are preparing now for the future of marijuana and hemp in America and worldwide."

STAY TUNED

Learn more about Marijuana, Inc. and its ground breaking business plan, and marketing models to be announced in an upcoming series of press releases starting this month and continuing on an ongoing basis.

CEO Bruce Perlowin stated, "We have been working in some cases for well over a year funding and developing products and services that have applications and marketing potential for the medical marijuana industry as well as related and similar industries".

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Marijuana, Inc. to be materially different from the statements made herein.

FOR FURTHER INFORMATION ON MARIJUANA, INC. (HEMP.PK) SEE:

www.marijuanainc.tv, www.ecoharmonycard.com, www.Kushclear.com, www.Wildherbnaturals.com, www.BrucePerlowin.com (sites under construction)

TO CONTACT MARIJUANA, INC.: [e-mail], [phone]

News Re-Release From October 17, 2011 For Those Who Missed It The First Time.





SOURCE Marijuana, Inc.

[SevenTenEleven]

MCUJ - Medicure Reports First Quarter 2012 Financial Results

Medicure (QB) (USOTC:MCUJ)

Today : Tuesday 29 November 2011



Medicure Inc. ("Medicure" or the "Company") (TSX VENTURE:MPH)(PINK SHEETS:MCUJ), a specialty pharmaceutical company, today reported its first quarter 2012 financial results.

First Quarter 2012 Highlights:


-- Net revenue from the sale of AGGRASTAT®increased 27% over the same
period last year, excluding the one-time sale of unfinished product
discussed below;
-- Net income for the period was $23.5 million, compared to a net loss of
$1.6 million for the same period last year is primarily due to a $23.9
million non-cash gain relating to the settlement of the Company's long-
term debt;
-- Settled debt of USD$32,839,659 owing to Birmingham Associates Ltd. in
exchange for the following consideration: (i) $4,750,000 in cash; (ii)
32,640,043 common shares of Medicure; and (iii) the granting of a
royalty on AGGRASTAT sales;
-- With the assistance of a guarantee from Dr. Albert Friesen, the Company
borrowed $5 million pursuant to a loan from the Manitoba Development
Corporation, to support the Company's ongoing operations; and
-- Completed a one-time sale of unfinished product to an international
pharmaceutical company, (Iroko Cardio LLC), for USD$1.9 million and an
option to access clinical and regulatory information recently used to
expand the approved use of AGGRASTAT in the European Union.

"Our success in restructuring over $32 million in debt while retaining over 70 percent of the ownership of the Company for existing shareholders reflects our ongoing commitment to the interests of shareholders as we seek to accelerate growth in sales of AGGRASTAT going forward." stated Dr. Albert Friesen, Chair and CEO of Medicure Inc.

Financial Results

Total net revenues in the first quarter increased to $1.5 million from $0.8 million for the same quarter last year. The increase in revenues for the first quarter of 2012 is largely attributable to a one-time sale to a European pharmaceutical company. There were no similar sales of unfinished products during the three months ended August 31, 2010.

Net revenue from the sale of finished AGGRASTAT product for the three months ended August 31, 2011 increased $228,000 or 27% to $1,058,000 from $830,000 for the same quarter last year. The increase is attributable to an increase in wholesale purchasing of AGGRASTAT, a reduction in hospital discounts and fluctuations in the U.S. dollar exchange rate. Although wholesale purchasing generally reflects hospital demand, it is also subject to fluctuations attributed to wholesaler inventory adjustments.

Net income for the quarter was $23.5 million or $0.15 per share, compared to a net loss of $1.6 million or ($0.01) per share in the first quarter a year ago.

At August 31, 2011, the Company had cash totalling $1,231,732 compared to $750,184 as of May 31, 2011. Cash flows from (used in) operating activities for the three months ended August 31, 2011 were $499,807, compared to ($34,202) for the three months ended August 31, 2010.

As further described in the Company's Management's Discussion and Analysis and in the notes to the financial statements for the three months ended August 31, 2011, the ability of the Company to continue as a going concern is dependent on many factors. The actions, described herein are intended to contribute to support the validity of the going concern assumption used in preparing the financial statements. There is no certainty that these actions or others will be sufficient to permit the Company to continue as a going concern.

Corporate Developments

On July 18, 2011, Medicure International, Inc. settled its long-term debt to Birmingham Associates Ltd. in exchange for; i) $4,750,000 in cash; ii) 32,640,043 common shares of Medicure Inc.; and iii) a royalty on future AGGRASTAT sales until 2023. The royalty is based on four percent of the first $2,000,000 of quarterly AGGRASTAT sales and the royalty increases on sales exceeding that amount. Also on July 18, the Company borrowed $5,000,000 from the Government of Manitoba, under the Manitoba Industrial Opportunities Program, to support the Company's ongoing operations. The loan is secured by the Company's assets, and guaranteed by Dr. Albert Friesen, Chair and CEO, and entities controlled by Dr. Friesen. The loan bears interest annually at the crown company borrowing rate plus two percent and matures on July 1, 2016. Further information on the loan is provided in notes to the quarter end financial statements.

On July 6, 2011, Medicure International, Inc. entered into an agreement with Iroko Cardio, LLC (Iroko) to advance AGGRASTAT in each of Medicure and Iroko's respective territories. Iroko owns rights to AGGRASTAT outside of the United States. Under the terms of the agreement, the Company transferred to Iroko AGGRASTAT unfinished product from inventory on hand and the rights to purchase additional quantities from a third party. In turn, Iroko paid Medicure International Inc. US$1,059,000 on July 6, 2011 and agreed to pay an additional US$850,000 on or before November 1, 2011, subject to certain conditions. The Company also received the option to access certain data used by Iroko to obtain changes to the approved use of AGGRASTAT in Europe. If the Company exercises its option to obtain the data and is successful in getting changes to the approved use of AGGRASTAT in the United States, Iroko will be entitled to receive a royalty of up to US$3.5 million on future AGGRASTAT sales based on a percentage of sales.

These transactions completed during the first quarter, together with focused capital conservation efforts over the past several quarters, have strengthened the Company and management estimates it has sufficient working capital and revenue to fund ongoing operations and selected product investments for the foreseeable future.

Product Developments

The ongoing focus of the Company and its primary asset of interest is AGGRASTAT. In parallel with its ongoing commitment to support and grow sales of the product, the Company is in the process of developing a new regulatory, brand and life cycle management strategy for AGGRASTAT. The objective of this effort is to further expand AGGRASTAT's share of the US$400 million glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitor market. GP llb/lla inhibitors are injectable platelet inhibitors used to treat acute coronary syndromes and related conditions.

Going forward and contingent on sufficient financial resources being available, the Company plans to invest in and implement its strategic plans related to AGGRASTAT and to explore the acquisition of other niche products that fit the commercial organization.

The Company also continues to advance TARDOXAL(TM) for the treatment of Tardive Dyskinesia through its ongoing Phase II TEND-TD clinical study. Tardive Dyskinesia is a motion disorder that is a common side effect of the use of antipsychotic drugs and effective treatment of this disorder would address an unmet medical need. The Company is also interested in the out-licensing of its library of small molecule antithrombotic drugs.

The Company's ability to continue in operation for the foreseeable future remains dependent upon the effective execution of its business development and strategic plans.

About Financial Statements and Transition to IFRS

In February 2008, the Canadian Accounting Standards Board (AcSB) confirmed that the use of International Financial Reporting Standards (IFRS) would be required for Canadian publicly accountable enterprises for interim and annual financial statements effective for fiscal years beginning on or after January 1, 2011. The Company implemented these standards on June 1, 2011. The unaudited condensed consolidated interim financial statements for the three months ended August 31, 2011 are the Company's first financial statements that comply with IFRS. Further information on this transition, comparisons to previous financial statements and the preparation of the financial statements are described in the notes of the condensed consolidated interim financial statements.

All amounts referenced herein are in Canadian dollars unless otherwise noted.

About Medicure Inc.

Medicure is a specialty pharmaceutical company focused on the development and commercialization of novel small molecule therapeutics. The primary focus of the Company and its subsidiaries is the marketing and distribution of AGGRASTAT® (tirofiban HCl) for acute coronary syndromes in the United States, where it is sold through the Company's US subsidiary, Medicure Pharma, Inc. For more information on Medicure please visit www.medicure.com.

To be added to Medicure's e-mail list, please visit: http://medicure.com/newsreleases.html.

Forward Looking Information Statements contained in this press release that are not statements of historical fact, including, without limitation, statements containing the words "believes", "may", "plans", "will", "estimates", "continues", "anticipates", "intends", "expects" and similar expressions, may constitute "forward-looking information" within the meaning of applicable Canadian and U.S. federal securities laws (such forward- looking information and forward-looking statements are hereinafter collectively referred to as "forward- looking statements"). Forward-looking statements are based on the current assumptions, estimates, analysis and opinions of management of the Company made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors which the Company believes to be relevant and reasonable in the circumstances. Inherent in forward-looking statements are known and unknown risks, uncertainties and other factors beyond the Company's ability to predict or control that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements, and as such, readers are cautioned not to place undue reliance on forward-looking statements.

Such risk factors include, among others, the Company's future product revenues, stage of development, additional capital requirements, risks associated with the completion and timing of clinical trials and obtaining regulatory approval to market the Company's products, the ability to protect its intellectual property, dependence upon collaborative partners, changes in government regulation or regulatory approval processes, and rapid technological change in the industry. Such statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to, assumptions about: general business and economic conditions; the impact of changes in Canadian-US dollar and other foreign exchange rates on the Company's revenues, costs and results; the timing of the receipt of regulatory and governmental approvals for the Company's research and development projects; the availability of financing for the Company's commercial operations and/or research and development projects, or the availability of financing on reasonable terms; results of current and future clinical trials; the uncertainties associated with the acceptance and demand for new products and market competition. The foregoing list of important factors and assumptions is not exhaustive. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements or the foregoing list of factors, other than as may be required by applicable legislation. Additional discussion regarding the risks and uncertainties relating to the Company and its business can be found in the Company's other filings with the applicable Canadian securities regulatory authorities or the US Securities and Exchange Commission, and in the "Risk Factors" section of its Form 20F for the year ended May 31, 2010.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:

Medicure Inc.

Dawson Reimer

President & COO

888-435-2220

204-488-9823 (FAX)

[e-mail]

www.medicure.com

http://ih.advfn.com/p.php?pid=nmona&article=50225199&symbol=MCUJ

[SevenTenEleven]

Keep your eye on MCUJ. Financials released a couple days ago still undiscovered by investors and groups looking for opportunity. More news to come, IMO. Playing it as a 5 bagger is conservative approach. I believe there is potential for it to his 10 or even 20 times the current PPS of $0.02.

[SevenTenEleven]

HEMP - Marijuana, Inc. Changes Stock Trading Symbol From "PCIO" to "HEMP"

Marijuana (PN) (USOTC:HEMP)

Today : Thursday 1 December 2011

Marijuana, Inc. Changes Stock Trading Symbol From "PCIO" to "HEMP"
PR Newswire

LAS VEGAS, Dec. 1, 2011

LAS VEGAS, Dec. 1, 2011 /PRNewswire/ -- Marijuana, Inc. (OTC: HEMP) announces its new symbol HEMP has been approved, thus signaling the aggressive launch of its various cannabis related industry divisions to be announced in upcoming press releases starting this week.

FINRA's communication stated: Please be advised that FINRA has received the necessary documentation to announce the symbol change for Marijuana, Inc. to HEMP. This corporate action will take effect at the open of business 10/10/11. The symbol on this date will be HEMP.

ABOUT MARIJUANA, INC.

Marijuana, Inc. (HEMP.pk) intends to focus on the huge peripheral businesses created by the quickly emerging, and growing, multibillion dollar medical marijuana and hemp industries.

Marijuana, Inc. will not be involved at the current time in growing, transporting or marketing medical marijuana itself – however it will be creating an infrastructure to do parts of this upon the companies expected legalization federally in all 50 states (pending any federal licensing or other requirements that may be enacted after marijuana prohibition ends).

CEO Bruce Perlowin stated, "Preparing for this potential change in the marijuana and industrial hemp laws by having one or more channels of distribution and industrial hemp manufacturing facilities in place ahead of time would give Marijuana, Inc. a distinct advantage in the marketplace while other peripheral industry business endeavors expand our brand awareness as well as targeting economically desirable and lucrative opportunities in this industry." www.marijuanainc.tv (still under construction).

President David Tobias also stated, "We are all now at the right place at the right time, with the right experience, to take advantage of an industry that has been around for thousands of years and rapidly emerging into mainstream countries as a new economic force in dozens of areas. Over the past few years it has become apparent that with the increasing pace of new products and services hitting the marketplace that this industry provides unique opportunities for a vast array of business ventures. Later this week, we will be announcing the launch into this market, our first of many products applicable to the medical marijuana and other related, or similar, industries that has never been applied here before."

STAY TUNED

Learn more about Marijuana, Inc. and its ground breaking business plan, and marketing models to be announced in an upcoming series of press releases starting this week and continuing on an ongoing basis.

CEO Bruce Perlowin stated, "We have been working in some cases for well over a year funding and developing products and services that have applications and marketing potential for the medical marijuana as well as related and similar industries."

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Marijuana, Inc. to be materially different from the statements made herein.

For further information on Marijuana Inc. (HEMP.PK) See:www.marijuanainc.tv, www.Kushclear.com, www.Wildherbnaturals.com, www.BrucePerlowin.com (sites under construction)

Contact Marijuana, Inc.: [e-mail], [phone]

News rereleased from October 10, 2011.

SOURCE Marijuana, Inc.

[SevenTenEleven]

CBIS - Cannabis Science Confirms Two Extract-Based Formulations Are Both Available Now at Cannabis Therapeutics & Marisol Therapeuti...

Cannabis Science (OTCBB:CBIS)

Today : Wednesday 30 November 2011


Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that the first two Cannabis Science Brand Formulations, Cannabis Science CT-1 and Cannabis Science MT-1 are now available at both Cannabis Therapeutics and Marisol Therapeutics exclusively for Colorado State licensed medical marijuana patients.

Cannabis Science MT-1:

Produced by Marisol Therapeutics: A family-owned shop, Marisol Therapeutics was founded to assist medical marijuana patients in obtaining medical marijuana in Colorado. They believe patients have the right to safe, confidential, quality medical marijuana and products. They recommend medical marijuana from their own experience with unrelenting and previously untreatable pain. “We understand, we care, we want you to heal.” Marisal Therapeutics has produced a custom blend of but is derived from their proprietary strains that were developed over 30 years by a Native American Vietnam veteran in order to address his medical needs. Cannabis Science CT-1 has been analyzed and shown to be free of insecticides and molds. The product is produced in soil under organic roof conditions. ADDRESS: 922 Kimble Drive Pueblo West, CO 81007 PHONE: [phone] EMAIL: [e-mail] and http://marisolmed.com/ for more information.

Cannabis Science CT-1:

Produced by Cannabis Therapeutics was Colorado’s first dispensary. Working with local law enforcement, state officials, legal experts, medical physicians, and researchers, Cannabis Therapeutics sets a standard of both safety and consistent quality to its members as well as the community at large. Cannabis Therapeutics is a professional medical business that employs all its policies and regulations to ensure the most stringent adherence to the law. Second in importance to legality is implementation of standardizing techniques to ensure both repeatability in dosing and quality of medicine. Cannabis Therapeutics began as an organization built by individuals that did not receive satisfactory relief from conventional therapies. Cannabis Therapeutics has produced a high quality cannabis extract from a custom blend of buds hydroponically grown medical marijuana strains. Cannabis Science CT-1 has been analyzed and shown to be free of insecticides and molds. ADDRESS: 907 E Fillmore St. Colorado Springs, CO 80907 http://www.cannabistherapeutics.net/ for more information.

The Company has been receiving a constant flow of new inquires via its website, emails, and telephone calls for cannabis-extract based medicines. For example, cancer patients seeking a quality, reproducible extract-based formulations for topical or internal use have frequently contacted Cannabis Science. In light of the accumulating anecdotal reports of the successful cancer treatments with cannabis extracts, the Company will continue to keep patients updated on current peer-reviewed scientific literature supporting the historical and modern use of cannabis to treat "tumors”. Unlike conventional treatment, cannabis medicines have an outstanding safety profile allowing patients in states with medical marijuana laws to safely make informed decisions to legally self-administration of various cannabis-based preparations.

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

[SevenTenEleven]

MWIP - MediSwipe Inc. Announces Completion Plans for S-1 Filing of 800 Commerce Subsidiary

Mediswipe (OTCBB:MWIP)

Today : Tuesday 29 November 2011


MediSwipe Inc. (www.MediSwipe.com) (OTCBB:MWIP.OB), a merchant payment solutions and financial products company for the medical health care industry, and its wholly owned subsidiary 800 Commerce Inc. (www.800Commerce.com), a leading enabler and turnkey e-commerce solution provider including mobile payment solutions, today announced that the company is in the final stages of preparation to file its S-1 registration statement on behalf of its subsidiary 800 Commerce. The company has also sought the assistance of an independent auditing firm to consolidate the 2010 financials of the 800 Commerce division and review the financial statements of the proposed VestiDigital acquisition.
"Although we at first set a very aggressive time frame for the filing of the S-1 registration, we are pleased that we are now in the final stages of the process. Whatever time has been lost on the front end due to legal and financial audit review of the documents, it is our belief that the completed document we submit will save us time in the long run during the approval process. We have also enlisted the help of our transfer agent and their investment banking arm to file the additional Form 15C211 at the same time of the registration statement. This will allow 800 Commerce to receive trading approval and an additional ticker symbol during the comment and effective waiting process. Once filed, each shareholder of MediSwipe will receive a pro rata share or dividend of 800 Commerce Inc., based upon the percentage of ownership within the parent company MediSwipe. Thus, to receive the dividend share all shareholders of record must own the parent company by the record date to be set by FINRA to be announced upon filing in the near future," stated Michael Friedman, CEO of MediSwipe Inc.

"We are also pleased to announce the first infusion of capital by an institutional investor of the first seventy-five thousand dollars to expand the growth of our operations. We have leased an additional 2,000 square feet of office space for 800 commerce in preparation of the spin off which will include a call center, social media and e-commerce staff and additional management. We have already produced results from our partnership with SparkBase as the first clients for our commerce cards and mobile payment system are already in production. We look forward to the completion of this registration process and moving toward a rewarding year for our loyal shareholders," added Friedman.

About MediSwipe Inc.

MediSwipe Inc. (www.MediSwipe.com) offers a full spectrum of secure and reliable transaction processing and security solutions for the medical and healthcare industries, using traditional, Internet Point-of-Sale (POS), e-commerce and mobile (wireless) payment solutions. The Company now also offers digitized personal health records in conjunction with Industry Alliance Partners. MediSwipe offers reliable merchant payment solutions and closed loop pre-paid stored value and loyalty cards as a unique cash alternative to these regulated and e-commerce businesses specializing within the healthcare sector.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.

CONTACT: MediSwipe Inc.
Investor Relations:
615.252.4099
[e-mail]

[Mikey]

reap, some penson clearing brokers are now using/ will be using LEK securities to clear through

[reaper247]

Mikey,

I believe you are right. I have looked and looked at this issue for months and have never gotten an answer from anyone.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=66437182

I have decided that your list is the most reliable on the net, and I do use it (and have been for awhile) as a reference.

My thoughts are that these brokers will find alternative clearing houses, rather than miss out opportunities to capitalize on the volatility of the OTC markets.

IMO and FWIW.

[SevenTenEleven]

That is why it is good to make sure that list i out there. Any company incorrectly on that list needs to be removed.

There are some who profit from "forcing" a company to fail, or make it appear like it has failed, or will fail.

Thanks to ICE for getting that list out there.

Shorty's days are numbered.

Tic Toc

[Mikey]

we have had several stocks magically 'lifted' from the 'brokers' list.........the shareholders filed a finra complaint and then promptly sent in links PROVING they werent on the nondtc list and like FM.........VOILA.........they were allowed to trade again.........you just have to get pushy and you may need to jump holler and scream, but it can be done

the brokers were zecco, mastertrader and direct.....and i think there were a couple of legent brokers too